Table 3 Proportions of cancer screening use according to USPSTF A, B, and C recommendations (weighted proportions)
From: Cancer screening outside of age recommendations: a population-based study
Any cancer screening (men and women) | Colorectal cancer screening (recommended to adults 45-85y/o) | Breast cancer screening (recommended to women 40-74y/o) | Cervical cancer screening (recommended to women 21-65y/o) | Prostate cancer screening (recommended to men 55-69y/o) | |||||
|---|---|---|---|---|---|---|---|---|---|
Age group (years) and screening engagement according to recommendations | All | Men | Women | Any | FOBT | Colonoscopy | Mammography | Uterine smear | PSA or rectal exam |
85+ | |||||||||
Not screened | 26.90% | 38.70% | 17.40% | 56.50% | 75.70% | 68.00% | 40.70% | 38.50% | 69.70% |
Within recommendations | 47.10% | 33.60% | 58.00% | 38.10% | 20.30% | 29.70% | 45.80% | 46.40% | 7.40% |
Outside of recommendations | 26.00% | 27.80% | 24.60% | 5.40% | 4.00% | 2.20% | 13.60% | 15.10% | 22.90% |
80–84 | |||||||||
Not screened | 19.20% | 33.40% | 6.30% | 52.30% | 78.80% | 63.00% | 30.30% | 22.90% | 59.90% |
Within recommendations | 38.00% | 33.10% | 42.40% | 47.70% | 21.20% | 37.00% | 41.30% | 36.90% | 6.60% |
Outside of recommendations | 42.80% | 33.50% | 51.20% | 0.00% | 0.00% | 0.00% | 28.40% | 40.10% | 33.50% |
75–79 | |||||||||
Not screened | 14.90% | 24.50% | 7.10% | 46.00% | 72.90% | 56.60% | 29.40% | 21.40% | 54.20% |
Within recommendations | 39.50% | 35.70% | 42.70% | 54.00% | 27.10% | 43.40% | 57.20% | 32.50% | 5.90% |
Outside of recommendations | 45.60% | 39.90% | 50.20% | 0.00% | 0.00% | 0.00% | 13.40% | 46.10% | 39.90% |
70–74 | |||||||||
Not screened | 12.90% | 22.50% | 4.50% | 41.80% | 71.80% | 53.60% | 25.20% | 14.70% | 47.20% |
Within recommendations | 41.80% | 47.80% | 36.50% | 58.20% | 28.20% | 46.40% | 74.80% | 26.30% | 23.00% |
Outside of recommendations | 45.30% | 29.80% | 59.00% | 0.00% | 0.00% | 0.00% | 0.00% | 59.00% | 29.80% |
65–69 | |||||||||
Not screened | 12.10% | 22.20% | 3.00% | 42.10% | 73.40% | 53.90% | 23.40% | 11.00% | 49.00% |
Within recommendations | 73.00% | 77.80% | 68.60% | 57.90% | 26.60% | 46.10% | 76.60% | 60.60% | 51.00% |
Outside of recommendations | 14.90% | 0.00% | 28.40% | 0.00% | 0.00% | 0.00% | 0.00% | 28.40% | 0.00% |
60–64 | |||||||||
Not screened | 14.10% | 25.70% | 2.80% | 48.50% | 76.00% | 58.40% | 28.90% | 7.90% | 46.30% |
!Within recommendations | 85.90% | 74.30% | 97.20% | 51.50% | 24.00% | 41.60% | 71.10% | 92.10% | 53.70% |
Outside of recommendations | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
55–59 | |||||||||
Not screened | 19.00% | 33.90% | 3.70% | 53.90% | 79.80% | 63.40% | 30.00% | 10.80% | 54.10% |
Within recommendations | 72.70% | 49.90% | 96.30% | 46.10% | 20.20% | 36.60% | 70.00% | 89.20% | 29.70% |
Outside of recommendations | 8.20% | 16.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.20% |
50–54 | |||||||||
Not screened | 27.00% | 48.20% | 5.70% | 68.50% | 85.70% | 77.10% | 43.60% | 11.90% | 66.60% |
Within recommendations | 55.60% | 18.20% | 93.40% | 30.30% | 14.30% | 21.80% | 56.40% | 88.10% | 0.00% |
Outside of recommendations | 17.40% | 33.60% | 0.90% | 1.10% | 0.00% | 1.10% | 0.00% | 0.00% | 33.40% |
45–49 | |||||||||
Not screened | 42.60% | 77.10% | 7.90% | 90.70% | 95.40% | 92.80% | 78.10% | 9.30% | 82.50% |
Within recommendations | 45.40% | 2.90% | 88.20% | 5.20% | 2.40% | 4.80% | 21.90% | 90.70% | 0.00% |
Outside of recommendations | 12.00% | 20.00% | 4.00% | 4.10% | 2.10% | 2.40% | 0.00% | 0.00% | 17.50% |
40–44 | |||||||||
Not screened | 44.90% | 87.30% | 7.60% | 93.60% | 96.40% | 96.60% | 84.70% | 10.10% | 92.50% |
Within recommendations | 43.50% | 0.00% | 81.70% | 0.00% | 0.00% | 0.00% | 10.50% | 89.90% | 0.00% |
Outside of recommendations | 11.60% | 12.70% | 10.70% | 6.40% | 3.60% | 3.40% | 4.80% | 0.00% | 7.50% |
35–39 | |||||||||
Not screened | - | - | 7.30% | - | - | - | 93.20% | 8.30% | - |
Within recommendations | - | - | 85.90% | - | - | - | 0.00% | 91.70% | - |
Outside of recommendations | - | - | 6.80% | - | - | - | 6.80% | 0.00% | - |
30–34 | |||||||||
Not screened | - | - | 10.10% | - | - | - | 91.80% | 11.90% | - |
Within recommendations | - | - | 81.70% | - | - | - | 0.00% | 88.10% | - |
Outside of recommendations | - | - | 8.20% | - | - | - | 8.20% | 0.00% | - |
25–29 | |||||||||
Not screened | - | - | 9.30% | - | - | - | 89.90% | 11.10% | - |
Within recommendations | - | - | 80.40% | - | - | - | 0.00% | 88.70% | - |
Outside of recommendations | - | - | 10.30% | - | - | - | 10.10% | 0.20% | - |
20–24 | |||||||||
Not screened | - | - | 34.00% | - | - | - | 96.20% | 34.00% | - |
Within recommendations | - | - | 49.70% | - | - | - | 0.00% | 52.70% | - |
Outside of recommendations | - | - | 16.30% | - | - | - | 3.80% | 13.30% | - |